维普中文期刊产品整合服务
4篇 您的检索式:作者名="Timo Hofmann"
    题名 作者 年代 出处 被引量
1In vitro activity-guided identification of antioxidants in aged garlic extract显示文摘Matsutomo Toshiaki Stark Timo D Hofmann Thomas 2013J Agric Food Chem2013,61,12:1
2Atmospheric-pressure plasma treatment of polyamide 6 composites for bonding with polyu- rethane显示文摘Jan Schafer Timo Hofmann Jens 2015Journal of Adhesion Science and Technology2015,29,17:1
3Heuristic solution of a joint electric control reserve and wholesale market model显示文摘A mixed integer linear programming(MILP)approach for the joint simulation of electric control reserve and electricity wholesale markets is presented.This generation dispatch model extends an existing integrated grid and electricity market(IGEM)model covering the Continental European electric power system.By explicitly incorporating the markets for primary and secondary control reserves(PCR and SCR),the model can reproduce the decisions of generating unit operators on which markets get involved.Besides,the introduction of the integrality conditions allows considering start-up costs and the calculus of generating units to pass through the economically unattractive periods with low or even negative prices in order to avoid another start-up.Since this model is too large to be solved with common MILP solvers for the intended simulation time of one year,temporal and geographical interdependencies are used to solve it heuristically.The heuristic therefore splits the model into various sub-problems so that on the one hand,the number of variables,especially of integer variables,per sub-problem is reduced significantly and on the other hand,the relevant interdependencies remain considered.The heuristic is evaluated in terms of accuracy and computation time by means of two case studies.Both case studies show satisfactory accuracy and significant advantages in computation time.Timo Breithaupt Thomas Leveringhaus Lutz Hofmann 2019International Journal of Modeling, Simulation, and Scientific Computing2019,10,2:0
4Cell:新分子或可有效清除肝脏和血液中的脂肪显示文摘肥胖和糖尿病持续上升代表着我们的社会所面临的一个重大的负担。脂肪肝和动脉粥样硬化是这些代谢疾病常见的后果,但是开发一种高效且又安全的能够逆转肥胖、胰岛素抵抗性、脂肪肝和动脉粥样硬化的药物仍然是全球头等的一项重大的科学挑战。Brian Finan Christoffer Clemmensen Zhimeng Zhu Kerstin Stemmer Karine Gauthier Luisa M uuml ller Meri De Angelis Kristin Moreth Frauke Neff Diego Perez-Tilve Katrin Fischer Dominik Lutter Miguel A. S aacute nchez-Garrido Peng Liu Jan Tuckermann Mohsen Malehmir Marc E. Healy Achim Weber Mathias Heikenwalder Martin Jastroch Maximilian Kleinert Sigrid Jall Sara Brandt Fr eacute d eacute ric Flamant Karl-Werner Schramm Heike Biebermann Yvonne D ouml ring Christian Weber Kirk M. Habegger Michaela Keuper Vasily Gelfanov Fa Liu Josef K ouml hrle Jan Rozman Helmut Fuchs Valerie Gailus-Durner Martin Hrabě de Angelis Susanna M. Hofmann Bin Yang Matthias H. Tsch ouml p Richard DiMarchi Timo D. M uuml ller 2017现代生物医学进展2017,17,4:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费